Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Diagnostic and Statistical Manual of Mental Disorders (DSM)

Diagnostic and Statistical Manual of Mental Disorders (DSM)

The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Merits and culprits of immunotherapies for neurological diseases in times of COVID-19.

EBioMedicine·2020

Same author

[Ocrelizumab for treatment of multiple sclerosis].

Der Nervenarzt·2020

Same author

Ocrelizumab shorter infusion: Primary results from the ENSEMBLE PLUS substudy in patients with MS.

Neurology(R) neuroimmunology & neuroinflammation·2020

Same author

Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study.

EBioMedicine·2020

Same author

COVID-19 and management of neuroimmunological disorders.

Nature reviews. Neurology·2020

Same author

Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis: A meta-analysis.

Neurology·2020

Search research articles

Related Experiment Video

Updated: May 20, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Multiple sclerosis: advances and challenges in diagnosis.

Silvia Tenembaum¹, Hans-Peter Hartung²

¹Pediatric Neurologist, Pediatric Neuroimmunology Clinic and Program, Department of Neurology, Hospital de Pediatría Dr J. Garrahan, Ciudad de Buenos Aires, Argentina.

Current Opinion in Neurology

|March 27, 2025

Summary

Recent advancements enhance multiple sclerosis (MS) diagnosis using neuroimaging. New criteria and markers improve early detection of MS in adults and children, aiding in understanding disease progression.

Keywords:

diagnostic criteria magnetic resonance imaging misdiagnosis multiple sclerosis neuroimaging advanced techniques

More Related Videos

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Related Experiment Videos

Last Updated: May 20, 2025

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Area of Science:

Neurology
Radiology
Neuroimmunology

Background:

Multiple Sclerosis (MS) diagnosis relies on clinical and imaging evidence.
Evolving understanding of MS pathogenesis necessitates updated diagnostic approaches.

Purpose of the Study:

To review recent developments in multiple sclerosis (MS) diagnostics.
To highlight advances in neuroimaging markers for MS diagnosis.
To discuss proposed revisions to MS diagnostic criteria and early disease concepts.

Main Methods:

Review of recent scientific literature on MS diagnosis.
Analysis of proposed changes to the 2024 MS diagnostic criteria.
Evaluation of advanced neuroimaging techniques and markers.

Main Results:

The 2024 MS diagnostic criteria revisions include the optic nerve as a topography and advanced MRI markers.
Radiologically Isolated Syndrome (RIS) is now considered for risk stratification.
Key imaging markers like the central vein sign, paramagnetic rim lesions, and cortical lesions show diagnostic utility in adult and pediatric MS. Advanced markers aid in understanding early disease progression.

Conclusions:

Recent studies significantly improve the accuracy of MS diagnosis in pediatric and adult patients.
Advances in neuroimaging offer potential for earlier detection and monitoring of MS progression.